Professor Elizabeth Tanner awarded an OBE for services to Biomedical Engineering.

Issued: Fri, 29 Jan 2016 16:19:00 GMT

Professor Liz Tanner is Professor of Biomedical Materials here at the University of Glasgow, and has recently received an OBE honouring her impressive career and dedication to her work in bone augmentation and replacement research. Liz started her career with a degree in Engineering Science at the University of Oxford, completed in 1979. Since then she has held a number of senior academic and teaching posts and has published more than 160 papers and book chapters. She joined the University of Glasgow in 2007. She has been elected Fellow Biomaterials Science and Engineering (FBSE), Fellow of the Royal Academy of Engineering (FREng) and in 2015, Fellow of the Royal Society of Edinburgh (FRSE).

Professor Tanner specialises in the development and use of bioactive materials for bone augmentation and replacement. She is currently leading a two-year study to help babies with rare breathing difficulties, funded by the children’s charity Action Medical Research. The aim is to design a new type of biodegradable stent especially for babies and young children who have severe breathing difficulties because their windpipe has not formed properly or has been damaged – by an infection, for example.

However, Liz’s interests extend beyond her own academic career. As Head of Biomedical Engineering Teaching from 2010-15, Liz has developed the first undergraduate BEng/MEng degree in Biomedical Engineering in Scotland which saw its first batch of students graduate in 2015. Interestingly, this first cohort had a very high number of women (compared to other engineering degrees), to the heights of 40%. This reflects another of Liz’s continuous efforts and interests, in helping more women take on and succeed in engineering careers.

Speaking about receiving an OBE, Professor Tanner said: “It was a delightful surprise. I am so pleased because it shows that the work I have been doing in biomedical engineering for the past 30 years has been worthwhile, benefitting people and patients”.